Adia Med of Winter Park LLC Autism Spectrum Disorder Research Study
NCT07304440
This study is recruiting at 2 US sites in 2 states, according to its ClinicalTrials.gov record last updated .
Summary
This 12-month study tests whether AdiaVita (umbilical cord blood-derived stem cells and exosomes) plus glutathione improves autism symptoms more than glutathione alone in children ages 3-12. About 100 children with confirmed autism will be randomly assigned to one of two groups. One group receives monthly IV AdiaVita plus IV glutathione for 3 months. The other group receives IV glutathione plus a saline placebo infusion for 2 months. Both groups also use a topical glutathione spray twice a day at home.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Autism Spectrum Disorder
- Autism
- ASD
- Autism Spectrum Disorder (ASD)
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 1
- Ages
- 3 to 12 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Adia Med of Winter Park LLC
- Last updated on ClinicalTrials.gov
- September 22, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Florida · 1
- Adia Med Of Winter Park · Winter Park, FL
Wisconsin · 1
- The Lyday Center · Green Bay, WI
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.